Clustering of clinical and echocardiographic phenotypes of covid-19 patients

Eran Shpigelman1, Aviram Hochstadt2,3,4, Dan Coster1

  • 1The Blavatnik School of Computer Science, Tel Aviv University, P.O. Box 39040, 6997801, Tel Aviv, Israel.

Scientific Reports
|May 31, 2023
PubMed

Insights

COVID-19 patients were classified into four subgroups using clinical and echocardiography data. These COVID-19 patient clusters revealed distinct disease patterns and prognoses, aiding in understanding heterogeneous cardiac involvement.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Data Science

Background:

  • COVID-19 infection causes heterogeneous cardiac involvement.
  • Understanding distinct patient phenotypes is crucial for elucidating disease pathogenesis.

Purpose of the Study:

  • To stratify hospitalized COVID-19 patients into distinct phenotypical subgroups.
  • To investigate the role of echocardiography and clinical markers in predicting COVID-19 patient outcomes.

Main Methods:

  • Applied k-prototypes algorithm to clinical and echocardiography data of 506 hospitalized COVID-19 patients.
  • Utilized Cox proportional hazard model to assess survival patterns across identified clusters.
  • Analyzed echocardiography variables for their discriminative power.

Main Results:

  • Four distinct patient clusters were identified based on age, cardiac indexes, and inflammatory response.
  • Clusters exhibited significantly different survival patterns, with Cluster 3 showing the worst prognosis.
  • Echocardiography-derived clusters demonstrated higher mortality prediction than clinical data alone.
  • Specific echocardiography variables (E' lat, E' sept, E/e average) showed high discriminative power.

Conclusions:

  • COVID-19 presents with distinct manifestations and prognoses across different patient clusters.
  • Echocardiography enhances the predictive power for mortality but its incremental value may not justify the data collection burden.
  • Older males with COVID-19 face a higher risk of deterioration compared to older females.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
17
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
12
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
17
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
12
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
38
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
24